Ixekizumab Treatment Patterns and Health Care Resource Utilization Among Patients with Axial Spondyloarthritis: A Retrospective United States Claims Database Study.

Abhijeet Danve Aisha VadhariyaJeffrey LisseArjun Cholayil Neha Bansal Natalia Bello Catherine Bakewell

Published in: Rheumatology and therapy (2024)

Despite high comorbidity burden and majority of the patients being biologic-experienced, patients initiating ixekizumab for axSpA showed favorable persistence profiles during the 12-month follow-up period.

Keyphrases

end stage renal disease
healthcare
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
rheumatoid arthritis
peritoneal dialysis
emergency department
health insurance
ankylosing spondylitis
patient reported outcomes
patient reported
electronic health record